Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) Tax Provisions (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Tax Provisions for 16 consecutive years, with $3.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Tax Provisions rose 176.45% to $3.7 million in Q4 2025 year-over-year; TTM through Nov 2025 was $4.6 million, a 69.12% increase, with the full-year FY2025 number at $4.6 million, up 69.12% from a year prior.
  • Tax Provisions was $3.7 million for Q4 2025 at Cryo Cell International, up from $436588.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $3.7 million in Q4 2025 to a low of -$606488.0 in Q4 2021.
  • A 5-year average of $510412.5 and a median of $325916.5 in 2022 define the central range for Tax Provisions.
  • Peak YoY movement for Tax Provisions: tumbled 196.15% in 2021, then surged 550.83% in 2024.
  • Cryo Cell International's Tax Provisions stood at -$606488.0 in 2021, then surged by 64.5% to -$215314.0 in 2022, then soared by 499.78% to $860786.0 in 2023, then skyrocketed by 54.99% to $1.3 million in 2024, then skyrocketed by 176.45% to $3.7 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Tax Provisions are $3.7 million (Q4 2025), $436588.0 (Q3 2025), and $219318.0 (Q2 2025).